Clinical Trial Update: Non-inferiority Trial of Dapaconazole Versus Ketoconazole [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing dapaconazole to ketoconazole for tinea pedis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Dapaconazole (Dapaconazole)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED